Ss-TEA: Entropy based identification of receptor specific ligand binding residues from a multiple sequence alignment of class A GPCRs

BMC Bioinformatics

Volumn 12, Issue , 2011, Pages

  Sanders, Marijn P A ^a   Fleuren, Wilco W M ^a   Verhoeven, Stefan ^b   van den Beld, Sven ^a   Alkema, Wynand ^b   de Vlieg, Jacob ^a,b   Klomp, Jan P G ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MSD   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

G-PROTEIN COUPLED RECEPTORS; HIGH-QUALITY SEQUENCES; LIGAND-BINDING RESIDUES; MULTIPLE SEQUENCE ALIGNMENTS; PHYSIOLOGICAL PROCESS; SEQUENCE CONSERVATION; SITE DIRECTED MUTAGENESIS; TRANSMEMBRANE DOMAIN;

BIOINFORMATICS;

LIGANDS;

G PROTEIN COUPLED RECEPTOR; LIGAND;

ANIMAL; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CLASSIFICATION; ENTROPY; HUMAN; METABOLISM; METHODOLOGY; PROTEIN BINDING; SEQUENCE ALIGNMENT;

ANIMALS; ENTROPY; HUMANS; LIGANDS; MODELS, MOLECULAR; PROTEIN BINDING; RECEPTORS, G-PROTEIN-COUPLED; SEQUENCE ALIGNMENT;

EID: 80053324221     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-12-332     Document Type: Article

References (57)

1. Klabunde T, Hessler G. Drug design strategies for targeting G-protein-coupled receptors. ChemBioChem 2002, 3(10):928-944. 10.1002/1439-7633(20021004)3:10<928::AID-CBIC928>3.0.CO;2-5, 12362358.
2. Hopkins AL, Groom CR. The druggable genome. Nat Rev Drug Discov 2002, 1(9):727-730. 10.1038/nrd892, 12209152.
3. Attwood TK, Findlay JB. Fingerprinting G-protein-coupled receptors. Protein Eng 1994, 7(2):195-203. 10.1093/protein/7.2.195, 8170923.
4. Kolakowski LF. GCRDb: a G-protein-coupled receptor database. Receptors Channels 1994, 2(1):1-7.
5. Horn F, Bettler E, Oliveira L, Campagne F, Cohen FE, Vriend G. GPCRDB information system for G protein-coupled receptors. Nucleic Acids Res 2003, 31(1):294-297. 10.1093/nar/gkg103, 165550, 12520006.
6. Jacoby E, Bouhelal R, Gerspacher M, Seuwen K. The 7 TM G-protein-coupled receptor target family. ChemMedChem 2006, 1(8):761-782.
7. Foord SM, Bonner TI, Neubig RR, Rosser EM, Pin JP, Davenport AP, Spedding M, Harmar AJ. International Union of Pharmacology. XLVI. G protein-coupled receptor list. Pharmacol Rev 2005, 57(2):279-288. 10.1124/pr.57.2.5, 15914470.
8. Kenakin T. Efficacy at G-protein-coupled receptors. Nat Rev Drug Discov 2002, 1(2):103-110. 10.1038/nrd722, 12120091.
9. Christopoulos A. Allosteric binding sites on cell-surface receptors: novel targets for drug discovery. Nat Rev Drug Discov 2002, 1(3):198-210. 10.1038/nrd746, 12120504.
10. Perez DM, Karnik SS. Multiple signaling states of G-protein-coupled receptors. Pharmacol Rev 2005, 57(2):147-161. 10.1124/pr.57.2.2, 15914464.
11. Maudsley S, Martin B, Luttrell LM. The origins of diversity and specificity in g protein-coupled receptor signaling. J Pharmacol Exp Ther 2005, 314(2):485-494. 10.1124/jpet.105.083121, 2656918, 15805429.
12. Urban JD, Clarke WP, von Zastrow M, Nichols DE, Kobilka B, Weinstein H, Javitch JA, Roth BL, Christopoulos A, Sexton PM, et al. Functional selectivity and classical concepts of quantitative pharmacology. J Pharmacol Exp Ther 2007, 320(1):1-13.
13. Okada T, Ernst OP, Palczewski K, Hofmann KP. Activation of rhodopsin: new insights from structural and biochemical studies. Trends Biochem Sci 2001, 26(5):318-324. 10.1016/S0968-0004(01)01799-6, 11343925.
14. Vernier P, Cardinaud B, Valdenaire O, Philippe H, Vincent JD. An evolutionary view of drug-receptor interaction: the bioamine receptor family. Trends Pharmacol Sci 1995, 16(11):375-381. 10.1016/S0165-6147(00)89078-1, 8578606.
15. Fredholm BB, AP IJ, Jacobson KA, Klotz KN, Linden J. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 2001, 53(4):527-552.
16. Janecka A, Fichna J, Janecki T. Opioid receptors and their ligands. Curr Top Med Chem 2004, 4(1):1-17.
17. Horuk R. Chemokine receptors. Cytokine Growth Factor Rev 2001, 12(4):313-335. 10.1016/S1359-6101(01)00014-4, 11544102.
18. Brown AJ, Jupe S, Briscoe CP. A family of fatty acid binding receptors. DNA Cell Biol 2005, 24(1):54-61. 10.1089/dna.2005.24.54, 15684720.
19. Chun J, Goetzl EJ, Hla T, Igarashi Y, Lynch KR, Moolenaar W, Pyne S, Tigyi G. International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature. Pharmacol Rev 2002, 54(2):265-269. 10.1124/pr.54.2.265, 12037142.
20. Brink C, Dahlen SE, Drazen J, Evans JF, Hay DW, Rovati GE, Serhan CN, Shimizu T, Yokomizo T. International Union of Pharmacology XLIV. Nomenclature for the oxoeicosanoid receptor. Pharmacol Rev 2004, 56(1):149-157. 10.1124/pr.56.1.4, 15001665.
21. Kostenis E. A glance at G-protein-coupled receptors for lipid mediators: a growing receptor family with remarkably diverse ligands. Pharmacol Ther 2004, 102(3):243-257. 10.1016/j.pharmthera.2004.04.005, 15246248.
22. Klabunde T. Chemogenomic approaches to drug discovery: similar receptors bind similar ligands. Br J Pharmacol 2007, 152(1):5-7. 10.1038/sj.bjp.0707308, 1978276, 17533415.
23. van Koppen CJ, Zaman GJ, Timmers CM, Kelder J, Mosselman S, van de Lagemaat R, Smit MJ, Hanssen RG. A signaling-selective, nanomolar potent allosteric low molecular weight agonist for the human luteinizing hormone receptor. Naunyn Schmiedebergs Arch Pharmacol 2008, 378(5):503-514. 10.1007/s00210-008-0318-3, 18551279.
24. Mouillac B, Chini B, Balestre MN, Elands J, Trumpp-Kallmeyer S, Hoflack J, Hibert M, Jard S, Barberis C. The binding site of neuropeptide vasopressin V1a receptor. Evidence for a major localization within transmembrane regions. J Biol Chem 1995, 270(43):25771-25777. 10.1074/jbc.270.43.25771, 7592759.
25. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le Trong I, Teller DC, Okada T, Stenkamp RE, et al. Crystal structure of rhodopsin: A G protein-coupled receptor. Science 2000, 289(5480):739-745. 10.1126/science.289.5480.739, 10926528.
26. Murakami M, Kouyama T. Crystal structure of squid rhodopsin. Nature 2008, 453(7193):363-367. 10.1038/nature06925, 18480818.
27. Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, Choi HJ, Kuhn P, Weis WI, Kobilka BK, et al. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 2007, 318(5854):1258-1265. 10.1126/science.1150577, 2583103, 17962520.
28. Warne T, Serrano-Vega MJ, Baker JG, Moukhametzianov R, Edwards PC, Henderson R, Leslie AG, Tate CG, Schertler GF. Structure of a beta1-adrenergic G-protein-coupled receptor. Nature 2008, 454(7203):486-491. 10.1038/nature07101, 2923055, 18594507.
29. Jaakola VP, Griffith MT, Hanson MA, Cherezov V, Chien EY, Lane JR, Ijzerman AP, Stevens RC. The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science 2008, 322(5905):1211-1217. 10.1126/science.1164772, 2586971, 18832607.
30. Cavasotto CN, Phatak SS. Homology modeling in drug discovery: current trends and applications. Drug Discov Today 2009, 14:(13-14):676-683.
31. Hubbard TJ, Aken BL, Ayling S, Ballester B, Beal K, Bragin E, Brent S, Chen Y, Clapham P, Clarke L, et al. Ensembl 2009. Nucleic Acids Res 2009, (37 Database):D690-697.
32. Madabushi S, Gross AK, Philippi A, Meng EC, Wensel TG, Lichtarge O. Evolutionary trace of G protein-coupled receptors reveals clusters of residues that determine global and class-specific functions. J Biol Chem 2004, 279(14660595):8126-8132.
33. Oliveira L, Paiva PB, Paiva AC, Vriend G. Sequence analysis reveals how G protein-coupled receptors transduce the signal to the G protein. Proteins 2003, 52(4):553-560. 10.1002/prot.10489, 12910455.
34. Ye K, Lameijer EW, Beukers MW, Ijzerman AP. A two-entropies analysis to identify functional positions in the transmembrane region of class A G protein-coupled receptors. Proteins 2006, 63(4):1018-1030. 10.1002/prot.20899, 16532452.
35. Bjarnadottir TK, Gloriam DE, Hellstrand SH, Kristiansson H, Fredriksson R, Schioth HB. Comprehensive repertoire and phylogenetic analysis of the G protein-coupled receptors in human and mouse. Genomics 2006, 88(3):263-273. 10.1016/j.ygeno.2006.04.001, 16753280.
36. Harmar AJ, Hills RA, Rosser EM, Jones M, Buneman OP, Dunbar DR, Greenhill SD, Hale VA, Sharman JL, Bonner TI, et al. IUPHAR-DB: the IUPHAR database of G protein-coupled receptors and ion channels. Nucleic Acids Res 2009, (37 Database):D680-685.
37. Ye K, Feenstra KA, Heringa J, Ijzerman AP, Marchiori E. Multi-RELIEF: a method to recognize specificity determining residues from multiple sequence alignments using a Machine-Learning approach for feature weighting. Bioinformatics 2008, 24(1):18-25. 10.1093/bioinformatics/btm537, 18024975.
38. Kim SK, Gao ZG, Van Rompaey P, Gross AS, Chen A, Van Calenbergh S, Jacobson KA. Modeling the adenosine receptors: comparison of the binding domains of A2A agonists and antagonists. J Med Chem 2003, 46(23):4847-4859. 10.1021/jm0300431, 14584936.
39. Ji I, Zeng H, Ji TH. Receptor activation of and signal generation by the lutropin/choriogonadotropin receptor. Cooperation of Asp397 of the receptor and alpha Lys91 of the hormone. J Biol Chem 1993, 268(31):22971-22974.
40. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990, 215(3):403-410.
41. The Universal Protein Resource (UniProt) in 2010. Nucleic Acids Res 2010, (38 Database):D142-148.
42. Jain E, Bairoch A, Duvaud S, Phan I, Redaschi N, Suzek BE, Martin MJ, McGarvey P, Gasteiger E. Infrastructure for the life sciences: design and implementation of the UniProt website. BMC Bioinformatics 2009, 10:136. 10.1186/1471-2105-10-136, 2686714, 19426475.
43. Ballesteros JA, W H. Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein coupled receptors. Methods Neurosci 1995, 25:366-428.
44. HMMER: Profile hidden Markov models for biological sequence analysis. , http://hmmer.janelia.org
45. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, et al. Clustal W and Clustal × version 2.0. Bioinformatics 2007, 23(21):2947-2948. 10.1093/bioinformatics/btm404, 17846036.
46. Rosenbaum DM, Cherezov V, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, Choi HJ, Yao XJ, Weis WI, Stevens RC, et al. GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function. Science 2007, 318(5854):1266-1273. 10.1126/science.1150609, 17962519.
47. Stitham J, Stojanovic A, Merenick BL, O'Hara KA, Hwa J. The unique ligand-binding pocket for the human prostacyclin receptor. Site-directed mutagenesis and molecular modeling. J Biol Chem 2003, 278(6):4250-4257. 10.1074/jbc.M207420200, 12446735.
48. Gerber BO, Meng EC, Dotsch V, Baranski TJ, Bourne HR. An activation switch in the ligand binding pocket of the C5a receptor. J Biol Chem 2001, 276(5):3394-3400. 10.1074/jbc.M007748200, 11062244.
49. Poso A, Huffman JW. Targeting the cannabinoid CB2 receptor: modelling and structural determinants of CB2 selective ligands. Br J Pharmacol 2008, 153(2):335-346. 10.1038/sj.bjp.0707567, 2219524, 17982473.
50. Raitio KH, Salo OM, Nevalainen T, Poso A, Jarvinen T. Targeting the cannabinoid CB2 receptor: mutations, modeling and development of CB2 selective ligands. Curr Med Chem 2005, 12(10):1217-1237. 10.2174/0929867053764617, 15892633.
51. Millar RP, Lu ZL, Pawson AJ, Flanagan CA, Morgan K, Maudsley SR. Gonadotropin-releasing hormone receptors. Endocr Rev 2004, 25(2):235-275. 10.1210/er.2003-0002, 15082521.
52. Sum CS, Tikhonova IG, Neumann S, Engel S, Raaka BM, Costanzi S, Gershengorn MC. Identification of residues important for agonist recognition and activation in GPR40. J Biol Chem 2007, 282(40):29248-29255. 10.1074/jbc.M705077200, 17699519.
53. Paterlini MG. Structure modeling of the chemokine receptor CCR5: implications for ligand binding and selectivity. Biophys J 2002, 83(6):3012-3031. 10.1016/S0006-3495(02)75307-1, 1302382, 12496074.
54. Costanzi S, Mamedova L, Gao ZG, Jacobson KA. Architecture of P2Y nucleotide receptors: structural comparison based on sequence analysis, mutagenesis, and homology modeling. J Med Chem 2004, 47(22):5393-5404. 10.1021/jm049914c, 15481977.
55. Ivanov AA, Costanzi S, Jacobson KA. Defining the nucleotide binding sites of P2Y receptors using rhodopsin-based homology modeling. J Comput Aided Mol Des 2006, 20:(7-8):417-426.
56. Gloriam DE, Foord SM, Blaney FE, Garland SL. Definition of the G protein-coupled receptor transmembrane bundle binding pocket and calculation of receptor similarities for drug design. J Med Chem 2009, 52(14):4429-4442. 10.1021/jm900319e, 19537715.
57. Clark RD, Webster-Clark DJ. Managing bias in ROC curves. J Comput Aided Mol Des 2008, 22(3-4):141-146. 10.1007/s10822-008-9181-z, 18256892.